Pharm-Olam is now Allucent. Learn More

Request a Proposal  

Mike Cannizzaro

Chairman of the Board

Pharm-Olam Pharm-Olam

Michael N. Cannizzaro is an accomplished leader in the healthcare product and services industry. His collective experiences span over 40 years in progressive and successful Director, Executive, and Senior Management roles in both publicly traded and privately held companies. He has experience at both a products and services level. His prior leadership experiences include several Fortune 50 companies. Some highlights from Mr. Cannizzaro’s career experiences include his roles as CEO of Sunrise Medical, Operating Partner at JW Childs Associates, and President of Beltone Electronics as well as roles with Caremark International, Baxter Healthcare, Leica North America, Wilson Sporting Goods, and Procter & Gamble.

Mr. Cannizzaro has a private consulting practice focusing on helping CEOs implement high performance strategies and partner in diligence processes. Prior to becoming the Chairman of the Board of Directors at Pharm-Olam, Mr. Cannizzaro was Chairman of the Board of Managers for Behavioral Health Group (BHG), a Dallas-based medication treatment and therapy company. BHG was a portfolio company of the Frontenac Company, a private equity firm based in Chicago. Mr. Cannizzaro assisted Frontenac in the pre-acquisition diligence process of BHG and, upon the successful acquisition of BHG, was appointed Chairman. Before that, he was Chairman of the Board of Directors for Sunrise Medical and the Deputy Chairman of Continental Anesthesia as well as CHG Healthcare. He was also on the Board of Crescent Healthcare.

Pharm-Olam Pharm-Olam

Mr. Cannizzaro’s earliest leadership experiences included domestic and international roles at Baxter Healthcare Corporation and Caremark International, where he led the Pharmacy Benefit Management division to record sales, doubling revenue in three years. Mike served in leadership roles of other private equity-backed companies, such as Beltone Electronics, a portfolio company of JW Childs Associates. Upon the successful sale of Beltone to a strategic buyer, Mike then became a Managing Director, and later an Operating Partner, of J. W. Childs Associates, focusing on acquisitions in the healthcare industry, and oversight and development of those acquisitions.

Mr. Cannizzaro attended John Carroll University as well as Loyola University of Chicago’s School of Business. He also took Executive Management Services seminars at Harvard Business School and completed an Executive Communications Program through Baxter Travenol Laboratories. Mr. Cannizzaro continues to remain active in the healthcare field through meaningful opportunities at the Executive and Board levels. He is known for his expertise in identifying the indispensable work that leaders must address to maximize their company’s P&L impact. Mr. Cannizzaro is a skilled sounding board for real business issues, knowing private equity from both sides of the table.